menu
Over 60 companies across the globe claim to manufacture drug products / drug
Over 60 companies across the globe claim to manufacture drug products / drug
Over 60 companies across the globe claim to manufacture drug products / drug

Over 60 companies across the globe claim to manufacture drug products / drug

The COVID-19 pandemichas severely impaired the overall pharmaceutical supply chain, mostly owing tothe absence of workers at manufacturing sites and restrictions imposed ondistribution networks. In this context, continuous manufacturing offers a viablesolution given the fact that continuous processes are largely automated. Infact, the FDA (and other regulatory bodies) have also expressed interest inadvocating a shift to the use of advanced manufacturing technologies, such ascontinuous manufacturing.

 

To order this 310+ page report, which features 110+ figuresand 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html

TheUSD 1.9 billion (by 2030) financial opportunity within the continuousmanufacturing market has been analyzed across the following segments:

§  Purposeof Manufacturing

§ In-House

§ Contract service

 

§  Scaleof Operation

§ Commercial

§ Preclinical /Clinical

 

§  Typeof Continuous Manufacturing related Service

§  APIManufacturing

§  EndProduct manufacturing

 

§  Typeof Drug Molecule

§ Biologic

§ Small Molecule

 

§  Typeof dosage form

§ Solid

§ Liquid

 

§  KeyGeographical Regions

§  North America

§  Europe

§  Asia Pacific

 

The ContinuousManufacturing Market (Small Molecules and Biologics), 2020 – 2030 reportfeatures the following companies, which we identified to be key players in thisdomain:

§ AbbVie ContractManufacturing

§ Ajinomoto Bio-PharmaServices

§ Almac

§ Boehringer IngelheimBioXcellence

§ Cambrex

§ CordonPharma

§ Hovione

§ Kaneka

§ Lonza

§ Patheon

§ SK biotek

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4.  Market Landscape

5. Companies with Expertise in ContinuousManufacturing in North America: Profiles

6. Companies with Expertise in ContinuousManufacturing in Europe: Profiles

7. Companies with Expertise in ContinuousManufacturing in Asia-Pacific: Profiles

8. Recent Partnerships and Collaborations

9. Recent Expansions

10. Capacity Analysis

11. Academic Grant Analysis

12. Patent Analysis

13. Initiatives of Companies with In-HouseContinuous Manufacturing Capabilities

14. Case Study: Modular Facilities inpharmaceutical / Biotechnological Industry

 

15. Case Study: Technology and EquipmentProviders

 

16. Case Study: Roadmap for the Adoption ofContinuous Manufacturing Processes

 

17.  Market Forecast and Opportunity Analysis

 

18. Conclusion

 

19. Executive Insights

 

20.  Appendix1: Tabulated Data

 

21.  Appendix2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com